Inno Laser Technology Co., Ltd. (SHE:301021)
China · Delayed Price · Currency is CNY 52.78
-6.03 (-10.25%)
Nov 13, 2026, 3:04 PM CST
Inno Laser Technology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 575.65 | 504.33 | 433.17 | 357.2 | 308.59 | 381.73 |
Other Revenue | 8.98 | 8.98 | 13.51 | 10.7 | 11.17 | 9.24 |
| 584.63 | 513.31 | 446.68 | 367.9 | 319.76 | 390.98 | |
Revenue Growth | 17.30% | 14.92% | 21.41% | 15.05% | -18.21% | 15.32% |
Cost of Revenue | 333.93 | 294.74 | 262.83 | 237.07 | 175.07 | 208.27 |
Gross Profit | 250.7 | 218.57 | 183.85 | 130.84 | 144.69 | 182.7 |
Selling, General & Admin | 88.46 | 82.99 | 84.37 | 77.38 | 72.17 | 72.24 |
Research & Development | 102.66 | 98.89 | 103.32 | 79.8 | 54.3 | 52.74 |
Other Operating Expenses | 12.89 | 5.08 | 4.9 | 4.19 | 2.87 | 3.09 |
Operating Expenses | 206.1 | 196.7 | 193.93 | 165.52 | 133.75 | 129.75 |
Operating Income | 44.61 | 21.86 | -10.08 | -34.69 | 10.95 | 52.95 |
Interest Expense | -0.92 | -0.8 | -0.96 | -0.5 | -0.36 | -2.2 |
Interest & Investment Income | 5.26 | 3.23 | 4.46 | 7.77 | 7.09 | 3.3 |
Currency Exchange Gain (Loss) | -0.88 | -0.88 | -0.43 | -0.86 | -4.27 | 1.51 |
Other Non Operating Income (Expenses) | -1.24 | -0.88 | -0.32 | -0.3 | 0.45 | -0.44 |
EBT Excluding Unusual Items | 46.83 | 22.53 | -7.33 | -28.59 | 13.85 | 55.12 |
Gain (Loss) on Sale of Investments | 0.21 | - | 0.03 | 0 | 0.02 | 0.05 |
Gain (Loss) on Sale of Assets | 1.47 | 1.16 | -0.03 | -0 | - | 0.39 |
Asset Writedown | -0.64 | -0.44 | -0.6 | -0.01 | -0 | -0.01 |
Other Unusual Items | 36.4 | 24.91 | 20.74 | 13.49 | 6.82 | 24.35 |
Pretax Income | 84.26 | 48.16 | 12.81 | -15.11 | 20.69 | 79.9 |
Income Tax Expense | 4.66 | 1.29 | -4.99 | -9.76 | -3.18 | 3.83 |
Earnings From Continuing Operations | 79.6 | 46.87 | 17.8 | -5.34 | 23.87 | 76.07 |
Minority Interest in Earnings | 1.29 | 1.46 | 4.03 | 0.84 | -1.3 | -1.16 |
Net Income | 80.89 | 48.32 | 21.83 | -4.5 | 22.57 | 74.91 |
Net Income to Common | 80.89 | 48.32 | 21.83 | -4.5 | 22.57 | 74.91 |
Net Income Growth | 87.85% | 121.35% | - | - | -69.86% | 14.24% |
Shares Outstanding (Basic) | 152 | 151 | 151 | 151 | 152 | 133 |
Shares Outstanding (Diluted) | 152 | 152 | 152 | 151 | 152 | 133 |
Shares Change | -0.15% | 0.01% | 0.15% | -0.41% | 14.67% | 16.73% |
EPS (Basic) | 0.53 | 0.32 | 0.14 | -0.03 | 0.15 | 0.56 |
EPS (Diluted) | 0.53 | 0.32 | 0.14 | -0.03 | 0.15 | 0.56 |
EPS Growth | 88.13% | 121.33% | - | - | -73.72% | -2.13% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Free Cash Flow | 118.71 | 7.95 | -57.99 | -30.95 | 59.84 | -4.45 |
Free Cash Flow Per Share | 0.78 | 0.05 | -0.38 | -0.20 | 0.39 | -0.03 |
Dividend Per Share | 0.100 | 0.100 | 0.100 | - | 0.100 | 0.120 |
Dividend Growth | 0% | 0% | - | - | -16.67% | - |
Gross Margin | 42.88% | 42.58% | 41.16% | 35.56% | 45.25% | 46.73% |
Operating Margin | 7.63% | 4.26% | -2.26% | -9.43% | 3.42% | 13.54% |
Profit Margin | 13.84% | 9.41% | 4.89% | -1.22% | 7.06% | 19.16% |
Free Cash Flow Margin | 20.30% | 1.55% | -12.98% | -8.41% | 18.71% | -1.14% |
EBITDA | 68.96 | 45.75 | 13.18 | -16.98 | 28.38 | 69.45 |
EBITDA Margin | 11.79% | 8.91% | 2.95% | -4.62% | 8.88% | 17.76% |
D&A For EBITDA | 24.35 | 23.88 | 23.26 | 17.7 | 17.43 | 16.5 |
EBIT | 44.61 | 21.86 | -10.08 | -34.69 | 10.95 | 52.95 |
EBIT Margin | 7.63% | 4.26% | -2.26% | -9.43% | 3.42% | 13.54% |
Effective Tax Rate | 5.53% | 2.68% | - | - | - | 4.79% |
Revenue as Reported | 584.63 | 513.31 | 446.68 | 367.9 | 319.76 | 390.98 |
Advertising Expenses | - | - | - | - | - | 2.37 |